Auburn Community Hospital (ACH) has achieved a significant milestone by becoming the first healthcare institution in the United States to integrate Abbott's Alinity h-series into its Core Laboratory. This cutting-edge hematology automation system is poised to revolutionize the capabilities of the Auburn Laboratory, particularly in the realm of complete blood count measurements, a critical diagnostic test widely used in patient care. By enhancing precision and efficiency, the new system will enable physicians to conduct more specific screenings for various conditions such as infections, anemia, immune system disorders, and blood cancers.

The implementation of this advanced technology not only elevates the ACH Core Lab to a level on par with renowned healthcare institutions worldwide but also underscores the longstanding partnership between ACH and Abbott, cultivated over two years. This development holds particular significance for ACH as it prepares to launch a comprehensive cancer center and initiate construction of the Auburn Heart Institute.

Dr. Ronald Kirshner, Chair of the Auburn Heart Institute, emphasizes the importance of this innovation in providing superior care to cardiology and cancer patients within the community. Furthermore, Abbott Alinity systems are lauded for their efficiency, enabling more tests to be conducted in less space, delivering faster results, and minimizing errors, ultimately leading to improved patient care. The successful integration of the Alinity-h system into the ACH lab is the result of collaborative efforts between the ACH team and Abbott, supported by comprehensive training at Abbott's Training Center in Dallas, Texas.

Source; prnewswire.com

 

 

Report Abuse